Results 151 to 160 of about 2,890 (187)
Some of the next articles are maybe not open access.
7 Glycogen and Starch Debranching Enzymes
1971Publisher Summary This chapter focuses on glycogen and starch debranching enzymes. The debranching enzymes can be divided into two classes—namely, direct debranching enzyme and indirect debranching enzymes. A “direct” debranching enzyme attacks unmodified glycogen or amylopectin, with hydrolysis of the 1→ 6 bond.
openaire +1 more source
The action of the glycogen debranching enzyme system in a muscle protein particle
Biochemical and Biophysical Research Communications, 1972Summary Recently a protein-glycogen particle has been isolated from rabbit muscle and shown to contain phosphorylase as well as phosphorylase kinase and phosphorylase phosphatase activity (1). We have found that the glycogen phosphorylase limit dextrin debranching enzyme system (amylo-l,6-glucosidase/oligo-1,4→1,4-glucantransferase) is also present ...
T E, Nelson, R C, White, T E, Watts
openaire +2 more sources
Analytical Biochemistry, 1981
Abstract Rabbit muscle glycogen debranching enzyme binds to all of a homologous series of ω-aminoalkyl agaroses. The debrancher can be eluted from ω-aminoethyl and ω-aminobutyl agarose with 0.5 m NaCl, and it desorbs more readily and elutes sooner from ω-aminoethyl agarose than from ω-aminobutyl agarose.
R C, White, C J, Ruff, T E, Nelson
openaire +2 more sources
Abstract Rabbit muscle glycogen debranching enzyme binds to all of a homologous series of ω-aminoalkyl agaroses. The debrancher can be eluted from ω-aminoethyl and ω-aminobutyl agarose with 0.5 m NaCl, and it desorbs more readily and elutes sooner from ω-aminoethyl agarose than from ω-aminobutyl agarose.
R C, White, C J, Ruff, T E, Nelson
openaire +2 more sources
Annals of Internal Medicine, 1992
To determine whether a specific subtype of glycogen storage disease type III is associated with myopathy and cardiomyopathy.Case series.Three referral medical centers.All patients with glycogen storage disease type III who were followed in 1990 and for whom both immunoblot analysis and clinical data were available.Evaluation for myopathy and ...
R A, Coleman +4 more
openaire +2 more sources
To determine whether a specific subtype of glycogen storage disease type III is associated with myopathy and cardiomyopathy.Case series.Three referral medical centers.All patients with glycogen storage disease type III who were followed in 1990 and for whom both immunoblot analysis and clinical data were available.Evaluation for myopathy and ...
R A, Coleman +4 more
openaire +2 more sources
American Journal of Physiology-Endocrinology and Metabolism, 2005
AMP-activated protein kinase (AMPK) regulates both glycogen and lipid metabolism functioning as an intracellular energy sensor. In this study, we identified a 160-kDa protein in mouse skeletal muscle lysate by using a glutathione- S-transferase (GST)-AMPK fusion protein pull-down assay.
Hideyuki, Sakoda +14 more
openaire +2 more sources
AMP-activated protein kinase (AMPK) regulates both glycogen and lipid metabolism functioning as an intracellular energy sensor. In this study, we identified a 160-kDa protein in mouse skeletal muscle lysate by using a glutathione- S-transferase (GST)-AMPK fusion protein pull-down assay.
Hideyuki, Sakoda +14 more
openaire +2 more sources
[95] Pullulanase (an amylopectin and glycogen debranching enzyme) from Aerobacter aerogenes
1966Publisher Summary This chapter discusses the preparation of pullulanase from Aerobacter aerogenes. Pullulan is a linear α-glucan produced by the yeastlike fungus Pullularia pullulans, in which about, 480 maltotriose units are linked by 1→ 6 glycosidic bonds. By pullulanase it is exclusively degraded to maltotriose units.
Hans Bender, Kurt Wallenfels
openaire +1 more source
Rhabdomyolysis as presenting symptom of glycogen debrancher enzyme deficiency
2005Pubblicato su "Basic and Applied Myology"
MUSUMECI, Olimpia +4 more
openaire +1 more source
Metal–Organic Framework-Based Enzyme Biocomposites
Chemical Reviews, 2021, Peter Wied, Francesco Carraro
exaly
American journal of human genetics, 1988
Type III glycogen storage disease is caused by a deficiency of glycogen debranching-enzyme activity. Many patients with this disease have both liver and muscle involvement, whereas others have only liver involvement without clinical or laboratory evidence of myopathy.
Y T, Chen +3 more
openaire +1 more source
Type III glycogen storage disease is caused by a deficiency of glycogen debranching-enzyme activity. Many patients with this disease have both liver and muscle involvement, whereas others have only liver involvement without clinical or laboratory evidence of myopathy.
Y T, Chen +3 more
openaire +1 more source
Bioinspired Framework Catalysts: From Enzyme Immobilization to Biomimetic Catalysis
Chemical Reviews, 2023Kun-Yu Wang, Jiandong Pang, Wei Shi
exaly

